Alnawaz Rehemtulla

Dr. Rehemtulla is an endowed Professor of Radiation Oncology at the University of Michigan School of Medicine and serves as an advisor to Imbio. He is focused on the development of imaging biomarkers to improve the diagnosis and treatment of cancer patients.

The majority of cancer patients are treated in part with ionizing radiation and Dr. Rehemtulla is well known among clinical Radiation Oncology departments. He has been instrumental in the development of the voxel-based technology and is a co-inventor on the licensed patents from the University of Michigan.

Dr. Rehemtulla has a 20-year history of developing products in the fields of cancer and cardiovascular disease. He trained at the Scripps Research Institute in La Jolla, where he developed technologies for diagnostic use in cardiovascular diseases. While at the Genetics Institute in Cambridge MA, he was involved in the development of protein therapeutics for Hemophilia A and B, both of which are in use clinically.